We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DE icon
201
Deere & Co
DE
$173B
$13.6M 0.11%
52,700
– –
BKNG icon
202
Booking.com
BKNG
$154B
$13.5M 0.11%
146,675
+25
+0% +$2.22K
IONS icon
203
Ionis Pharmaceuticals
IONS
$9.14B
$13.4M 0.11%
246,954
– –
HUM icon
204
Humana
HUM
$46.7B
$13.3M 0.11%
33,821
– –
ARRY icon
205
Array Technologies
ARRY
$785M
$13.3M 0.11%
320,484
-29
-0% -$1.16K
XOM icon
206
ExxonMobil
XOM
$634B
$13.2M 0.11%
334,520
– –
DG icon
207
Dollar General
DG
$27.8B
$13.2M 0.11%
65,162
– –
CEVA icon
208
CEVA Inc
CEVA
$883M
$13.1M 0.11%
299,691
– –
RARE icon
209
Ultragenyx Pharmaceutical
RARE
$2.56B
$13.1M 0.11%
98,429
– –
PKG icon
210
Packaging Corp of America
PKG
$22.6B
$13M 0.11%
98,444
– –
BLK icon
211
Blackrock
BLK
$170B
$13M 0.11%
18,810
– –
NAV
212
DELISTED
Navistar International
NAV
$12.9M 0.11%
305,169
– –
PAGS icon
213
PagSeguro Digital
PAGS
$2.69B
$12.8M 0.11%
234,950
– –
SHW icon
214
Sherwin-Williams
SHW
$87.4B
$12.7M 0.11%
53,961
– –
COST icon
215
Costco
COST
$429B
$12.7M 0.11%
35,014
– –
GS icon
216
Goldman Sachs
GS
$305B
$12.5M 0.1%
49,386
– –
AMRC icon
217
Ameresco
AMRC
$1.04B
$12.5M 0.1%
249,002
-3
-0% -$165
XLNX
218
DELISTED
Xilinx Inc
XLNX
$12.3M 0.1%
90,396
– –
ARWR icon
219
Arrowhead Research
ARWR
$12.1B
$12.1M 0.1%
163,958
– –
SAGE
220
DELISTED
Sage Therapeutics
SAGE
$12M 0.1%
144,647
– –
TREX icon
221
Trex
TREX
$4.57B
$12M 0.1%
148,672
+2
+0% +$188
BE icon
222
Bloom Energy
BE
$47.5B
$11.9M 0.1%
433,059
-3
-0% -$98
NEM icon
223
Newmont
NEM
$96.4B
$11.9M 0.1%
207,201
+9
+0% +$538
HOLI
224
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$11.9M 0.1%
844,237
– –
TCRR
225
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$11.7M 0.1%
394,288
+6
+0% +$164
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.